Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | NDUFS8 | O00217 | 1/20 | 0.47 |
| ▸ | COXFA4 | O00483 | 1/20 | 0.47 |
| ▸ | NDUFAB1 | O14561 | 1/20 | 0.47 |
| ▸ | NDUFA1 | O15239 | 1/20 | 0.47 |
| ▸ | NDUFS4 | O43181 | 1/20 | 0.47 |
| ▸ | NDUFB5 | O43674 | 1/20 | 0.47 |
| ▸ | NDUFB3 | O43676 | 1/20 | 0.47 |
| ▸ | NDUFC1 | O43677 | 1/20 | 0.47 |
| ▸ | NDUFA2 | O43678 | 1/20 | 0.47 |
| ▸ | NDUFS5 | O43920 | 1/20 | 0.47 |
| ▸ | NDUFS7 | O75251 | 1/20 | 0.47 |
| ▸ | NDUFS2 | O75306 | 1/20 | 0.47 |
| ▸ | NDUFS6 | O75380 | 1/20 | 0.47 |
| ▸ | NDUFB1 | O75438 | 1/20 | 0.47 |
| ▸ | NDUFS3 | O75489 | 1/20 | 0.47 |
| ▸ | NDUFB6 | O95139 | 1/20 | 0.47 |
| ▸ | NDUFA3 | O95167 | 1/20 | 0.47 |
| ▸ | NDUFB4 | O95168 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18265469 | 0.95 | LTA4H (0.53) | LTA4HEPHX2NDUFS8COXFA4NDUFAB1 | |
| Etrogol SCHEMBL18265493 | 0.88 | NDUFS8 (0.50) | LTA4HEPHX2NDUFS8COXFA4NDUFAB1 | |
| SCHEMBL11570459 | 0.81 | NDUFS8 (0.46) | LTA4HNDUFS8COXFA4NDUFAB1NDUFA1 | |
| SCHEMBL23266200 | 0.81 | NDUFS8 (0.48) | NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4 | |
| SCHEMBL8036010 | 0.80 | KDM4E (0.53) | NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4 | |
| SCHEMBL25806392 | 0.80 | TAAR1 (0.52) | NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4 | |
| SCHEMBL23642842 | 0.80 | LTA4H (0.50) | LTA4HEPHX2ALDH1A1MEN1USP2 | |
| SCHEMBL8618406 | 0.79 | LTA4H (0.50) | LTA4HEPHX2ALDH1A1MEN1USP2 | |
| SCHEMBL9262789 | 0.78 | ALDH1A1 (0.50) | ALDH1A1MEN1LMNACYP3A4KMT2A | |
| SCHEMBL9026418 | 0.78 | KMT2A (0.55) | LTA4HEPHX2ALDH1A1MEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11325937-B2 | Glycoside compound and preparation method therefor, composition, application, and intermediate | SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED (CN) | 2022-05-10 | — | — | US | disclosed |
| EP-3819303-A1 | GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE | Shanghai Hutchison Pharmaceuticals Limited (CN) | 2021-05-12 | — | — | EP | disclosed |
| US-20210115082-A1 | GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE | SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED (CN) | 2021-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325937-B2 | Glycoside compound and preparation method therefor, composition, application, and intermediate | VEGFA, FLT4, FLT1 | LTA4H 2112/4885EPHX2 2972/4885NDUFS8 781/4885 |
| US-20210115082-A1 | GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE | VEGFA, FLT4, FLT1 | LTA4H 2112/4885EPHX2 2972/4885NDUFS8 781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.